This Article  • Full text  • PDF  • CME Course for This Article  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • Infectious Diseases, Other  • Pediatric Otolaryngology  • Pediatrics  • Pediatrics, Other  • Drug Therapy  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Iman Naseri, MD; Robert C. Jerris, PhD; Steven E. Sobol, MD, MSc

Arch Otolaryngol Head Neck Surg. 2009;135(1):14-16.

Objectives  To evaluate the epidemiologic manifestations of pediatric Staphylococcus aureus head and neck infections nationwide and to identify possible trends in the antibiotic drug susceptibility of S aureus during a 6-year period.

Design  Retrospective review of microbiologic data from a peer-reviewed national database.

Setting  More than 300 hospitals nationwide.

Patients  All pediatric patients with head and neck infections involving S aureus.

Main Outcome Measures  Anatomic sites were divided into oropharynx/neck, sinonasal, and otologic infection categories. Demographic and antimicrobial drug susceptibility patterns were reviewed.

Results  A total of 21 009 pediatric head and neck S aureus infections that occurred between January 2001 and December 31, 2006 were gathered from the database. Predominance was observed in the oropharyngeal/neck category (60.3%). For all sites, the mean patient age was 6.7 years (range, 0-18 years), with a 51.7% male predominance. There was a high occurrence in the North East Central region of the United States. Overall, methicillin-resistant S aureus was seen in 21.6% of all patient isolates (n = 4534), with rates of 11.8%, 12.5%, 18.1%, 27.2%, 25.5%, and 28.1% for 2001 through 2006, respectively. This represents a 16.3% increase in methicillin-resistant S aureus during these 6 years for all pediatric head and neck S aureus infections.

Conclusions  There is an alarming nationwide increase in the prevalence of pediatric methicillin-resistant S aureus head and neck infections. Disparities in the treatment of various head and neck infections nationwide may contribute to the regional differences in the prevalence of such infections. Judicious use of antibiotic agents and increased effectiveness in diagnosis and treatment are warranted to reduce further antimicrobial drug resistance in pediatric head and neck infections.

Author Affiliations: Departments of Otolaryngology–Head and Neck Surgery (Dr Naseri) and Pediatric Otolaryngology (Dr Sobol), Emory University School of Medicine, Atlanta, Georgia; and Children's Healthcare of Atlanta, Egleston Hospital (Dr Jerris).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Methicillin-Resistant Staphylococcus aureus in Middle Ear Fluid of Children
Klein and Chan
CLIN PEDIATR 2010;49:66-68.
ABSTRACT  

Nationwide Increase in Antibiotic-Resistant Head and Neck Infections in Children
JWatch Pediatrics 2009;2009:3-3.
FULL TEXT